Saturday, October 1, 2022

Health News Roundup: Canada, first in the world, to propose health warnings on individual cigarettes; US drops COVID testing for incoming international air travelers and more Health

The following is a brief overview of current health news.

Canada, first in the world, proposes health warnings on individual cigarettes

Canada is proposing to have a written health warning printed on individual cigarettes, the first country in the world to do so, a federal minister said Friday. In 2001, Canada set new ground globally by requiring picture warnings on cigarette packages. The measure has gone rancid for 13% of Canadians who smoke regularly, said Carolyn Bennett, Minister of Mental Health and Addictions.

US drops COVID testing for incoming international air travelers

The United States late Friday revoked a 17-month-old requirement that people arriving in the country test negative for COVID-19, a move that follows intense lobbying by airlines and the travel industry. Rochelle Valensky, director of the Centers for Disease Control and Prevention (CDC), issued a four-page order https://www.cdc.gov/quarantine/pdf/rescission-global-testing-order-p.pdf.pdf effectively implementing the mandate. Picking up from 12:01 a.m. ET (0400 GMT) Sunday, saying it’s “currently not required.”

US FDA staff says Moderna COVID vaccine is effective and safe for children

Moderna Inc.’s COVID-19 vaccine appears to be safe and effective for use in children aged 6 months to 17 years, US Food and Drug Administration staff reviewers said Friday, as a committee of scientists will meet next week to determine whether Recommendation to authorize the regulator. Vaccines in children. FDA reviewers said in briefing documents published Friday evening that the vaccine produced a similar immune response in children compared to adults in previous trials.

N.Korea reports 40,060 more people with fever symptoms amid COVID outbreak -KCNA

North Korea on Sunday reported 40,060 new people showing signs of fever and one death in isolation amid the country’s first confirmed COVID-19 outbreak, state media KCNA said.

Valneva is working on a treatment plan for a COVID-19 vaccine candidate

French drugmaker Valneva said on Friday it had proposed a treatment plan for its inactivated COVID-19 vaccine candidate after receiving a European Commission notice of intent to terminate an advance purchase agreement. “Some member states have reaffirmed their interest in having an inactivated, adjuvant full-virus vaccine solution in their portfolios,” the company said in a statement.

White House says Delta will ship UK baby formula from June 20

Delta Air Lines Inc. will begin transporting 3.2 million bottles of Kendamil Baby Formula on June 20, the White House said on Friday, announcing its sixth shipment of foreign formula to help address US shortages. Delta will ship approximately £212,000 of the British Formula maker’s product from London to Boston and Detroit, where it will be received by retailers, the White House said in a statement.

FDA requires disclosure of suicide risk for anti-baldness drug

US health regulators rejected a request to remove the popular anti-baldness pill Propecia and its generic versions from the market, but required patient notification about reports of suicidal behavior in men taking the drug for the first time. The US Food and Drug Administration previously approved a revised Propecia label that noted the risk of persistent sexual dysfunction and depression but not suicide. A patient advocacy group, the Post-Finasteride Syndrome Foundation, petitioned the FDA in 2017 to order Merck & Co. to stop selling the drug or require more robust warnings, citing multiple scientific studies. Finasteride is the generic name for Propecia.

Bluebird Bio’s gene therapy for blood disorder gets FDA panel’s backing

Bluebird Bio’s treatment for a rare blood disorder was backed by advisers from the US Food and Drug Administration on Friday, in a vote of confidence in gene therapy and the company beset by regulatory setbacks. The decision comes less than 24 hours after the same committee, in a surprise move, approved Bluebird’s other gene therapy, Alli-Cell, for a rare neurological disease, despite concerns that the treatment could cure cancer. could be the reason.

US seeks to expand monkeypox testing as cases rise

US health officials are working to expand capabilities to test for monkeypox beyond a narrow set of public health laboratories, prompting calls from infectious disease experts that testing for the virus needs to become part of routine care. Director of the US Centers for Disease Control and Prevention (CDC), Dr. Rochelle Valensky said during a conference call Friday that her agency is working with the Food and Drug Administration and the Centers for Medicare and Medicaid Services (CMS) to expand testing capacity. laboratories.

China reports 275 new COVID cases for June 11 versus 275 a day earlier

Mainland China reported 275 new coronavirus cases for June 11, of which 134 were symptomatic and 141 were asymptomatic, the National Health Commission said on Sunday. This was up from 210 new cases a day earlier – 79 symptomatic and 131 asymptomatic infections, which China counts separately.

(With input from agencies.)

Nation World News Desk
Nation World News Deskhttps://nationworldnews.com
Nation World News is the fastest emerging news website covering all the latest news, world’s top stories, science news entertainment sports cricket’s latest discoveries, new technology gadgets, politics news, and more.
Latest news
Related news
- Advertisement -